Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
addiction, heroin
addiction, heroin-neurologic complications with
adverse drug reaction
akinetic mute
algorithm
alternating rapid movement
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta-related angiitis
aneurysm
aneurysm, internal carotid artery
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
angiitis, isolated of CNS, benign focal
angiography, cerebral, beaded vessels
angiography, cerebral
angiography, cerebral, false negative
angiography, cerebral, reversible abnormality
anosmia
anti MAG antibodies
anti Ro antibody
anti Yo antibody
antibodies to myelin basic protein
antimyelin antibodies
aphasia
arteriopathy
arteritides
arteritis, temporal
arthralgia
asymptomatic
ataxia
ataxia, cerebellar
ataxia, progressive
ataxia, truncal
ataxic gait
atrial myxoma
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
axonal degeneration
axonal transection
B 12 deficiency
Babinski sign
Barkhof MR criteria for MS
basal ganglia, infarction
basal ganglia, lesion of
BCG vaccination
behavioral disorder
Behcet's syndrome
BENEFIT study
bone marrow biopsy
bradykinesia
bradyphrenia
brain atrophy
brain biopsy
brain biopsy, false negative
brain volume
brainstem
brainstem, atrophy
brainstem, infarction of
brainstem, lesion of
bulbar palsy
calcium antagonist
Call-Fleming syndrome
carbamazepine
carbon monoxide poisoning
carcinoma
carcinoma of breast
CAT scan
CAT scan, abnormal
CAT scan, contrast enhanced, delayed
CAT scan, contrast enhanced, double dose
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, serial
central nervous system, infection of
central pontine myelinolysis
cerebellar ataxia, primary
cerebellar atrophy, primary
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellum
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral edema
cerebral edema, vasogenic
cerebral infarction
cerebral infarction, hemorrhagic
cerebral infarction, small, deep
cerebral infarction, subcortical
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, culture of
cerebrospinal fluid, culture of, viral
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
cerebrospinal fluid, red cells in
cerebrovascular accident
cerebrovascular accident, bilateral
cerebrovascular accident, familial occurrence
cerebrovascular accident, multiple
cerebrovascular accident, recurrent
cerebrovascular accident, women
cervical spine
chasing the dragon
chemotherapy, CNS treatment and complications with
children
chin numbness
chromosomal abnormality
Clinical Pathologic Conference(C.P.C.)
cognition
collagen vascular disease
coma
complications
confusion
confusional state, acute
controversies in neurology
cop 1
corpus callosum
corpus callosum, lesion of
cortical blindness
crying, pathologic
cyclophosphamide
deep gray nuclei
degenerative diseases of CNS
dementia
dementia, rapidly progressive
dementia, screening for
demyelinating disease
dental procedure, neurologic complications with
depression
diabetes insipidus
diabetes mellitus
diagnostic criteria
differential diagnosis
diplopia
disability rating scale, neurological
disability, neurological
dizziness
drug abuse
drug abuse, inhalation
drug abuse, neurologic complications of
drug induced neurologic disorders
dysarthria
dysdiadochokinesia
dysmetria
dysphagia
dysphonia
dystonia
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electromyogram
emotional lability
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, viral
encephalopathy
encephalopathy, Hashimoto's
encephalopathy, metabolic
endocarditis
epidemiology of neurology
Epstein-Barr virus
Erdheim-Chester disease
ethics in neurology
evoked potentials
extinction on double simultaneous stimulation
eye movement, disorders of
face, numbness of
facial weakness
facial weakness, bilateral
falling
familial
food-borne infection
fourth ventricle, shift of
gadolinium
gait disorder
gammaglobulin therapy, intravenous
gastroenteritis
gaze palsy
gaze palsy, horizontal
gender
gene mutation
genetic neurologic disorders
gliomatosis cerebri
glutamic acid decarboxylase, antibody
granular osmiphilic material
granulomatous disease
head nodding
headache
headache, recurrent
headache, severe
headache, sudden onset of
headache, thunderclap
hearing loss
hearing loss, sudden, unilateral
heel-knee-shin test
hemianopia, homonymous
hemianopia, isolated homonymous
hemiparesis
hepatolenticular degeneration(Wilson's disease)
heralding manifestation
herpes simplex virus
herpes virus
herpes zoster
herpes zoster, ophthalmicus
hiccoughs
histiocytosis
human immunodeficiency virus type 1
human immunodeficiency virus type 1, asymptomatic
hydrocephalus
hydrocephalus, exvacuo
hyperreflexia
hypersomnia
hypertensive encephalopathy
iatrogenic neurologic disorders
immunomodulation
immunosuppressive agents
incoordination
intellectual deficit
intellectual deterioration
interferon
interferon beta 1-a
interferon beta 1-b
internal capsule
internuclear ophthalmoplegia
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intravenous
Jakob-Creutzfeldt disease
Kayser-Fleischer ring
laughing, pathologic
leukoencephalopathy
leukoencephalopathy, differential diagnosis
leukoencephalopathy, toxic
level of consciousness, decreased
limbic encephalitis
listeria monocytogenes
listeriosis, CNS
liver disease
locked-in syndrome
long bone lesion
low back pain
Lyme disease
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
MAGNIMS group
McDonald criteria for MS
medulla oblongata, lesion of
memory, impairment of
meningeal biopsy
meningeal enhancement
meningismus
meningitis, aseptic
mental nerve
mental nerve neuropathy
mental status, abnormal
migraine
mimics
misdiagnosis
mitochondrial disease
mitoxantrone
monoparesis
mood change
mortality
motor neuron disease
MRI
MRI, abnormal
MRI, angiography
MRI, angiography, false negative
MRI, contrast enhanced
MRI, demyelinating disease
MRI, diffusion weighted
MRI, false negative
MRI, field strength
MRI, field strength, high
MRI, incidental finding
MRI, lesion burden
MRI, negative
MRI, optic nerve
MRI, protocol
MRI, serial
MRI, snowball lesions
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, clinically isolated syndrome
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, etiology of
multiple sclerosis, familial
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pain in
multiple sclerosis, paroxysmal symptoms in
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
mutism
myelitis
myelopathy
myoclonus
N-acetyl-L-aspartic acid
nausea and vomiting
neoplasm, metastatic
neoplasm, primary intracerebral
neoplasm, primary of CNS
neurologic disease, diagnoses of
neurologic examination, focal
neurologic signs
neurologic symptoms
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuroophthalmology
neuropathology
neuroprotective agents
Notch3 gene
numb chin syndrome
nystagmus
nystagmus, primary position of gaze
ocular bobbing
optic nerve, lesion of
optic neuritis
optic neuritis, etiology of
optic neuritis, treatment of
optical coherence tomography
optokinetic nystagmus(O.K.N.)
optokinetic nystagmus, abnormal
osteoblastic lesions, causes of
pain
pain, back
paraneoplastic cerebellar degeneration
paraparesis
paraparesis, spastic
paresthesias
Parkinson disease
Parkinsonism syndrome
paroxysmal neurologic deficits
PAS positive
PAS positive material in the brain
periventricular leukomalacia
personality change
phenylketonuria
pleocytosis of cerebrospinal fluid
pons, infarction of
pons, lesion of
posterior fossa
posterior fossa, lesion of
posterior leukoencephalopathy syndrome
postpartum
practice guidelines
precipitating factors
pregnancy, neurologic complications in
prevention of neurologic disorders
primary lateral sclerosis
prion disease
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
protein 14-3-3, cerebrospinal fluid
pseudobulbar palsy
psychiatric problems in neurologic disorders
pursuit eye movements, abnormal
pyramidal tract
pyramidal tract dysfunction
quadriparesis
quadriplegia
race
radiation therapy, CNS treatment and complications with
Rankin score
rapidly progressing neurologic illness
Red flags
rehabilitation for neurologic disorders
remote effect of cancer on the nervous system
reversible cerebral vasoconstrictive syndromes
reversible neurologic disorder
review article
rheumatoid arthritis factor(R.A.factor)
rigidity
risk factors
saccadic eye movements, abnormal
safety
sarcoidosis
sarcoidosis, CNS
Schilder's disease
scotoma
scotoma, paracentral-homonymous
sedimentation rate, elevated
seizure
sensorineural hearing loss
serologic testing
sickle cell disease
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
skew deviation
spasticity
speech disorder
speech, loss of
spinal cord
spinal cord, cervical
spinal cord, ischemic lesion of
spinal cord, lesion of
standing difficulty
steroid
steroid therapy, CNS treatment and complications with
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
suicide
Susac's syndrome
symmetric brain lesions
symptomatic
systemic lupus erythematosus
systemic lupus erythematosus, neurologic complications with
tandem gait, ataxic
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
thyroiditis
tinnitus
tongue, impaired movements of
tonic spasms
toxic encephalopathy
treatment of neurologic disorder
tremor
trigeminal neuralgia
trigeminal neuropathy
trigeminal neuropathy, sensory
vasculitides
vasculopathy
vasoconstrictive drugs
vasospasm, cerebral
ventricular enlargement
vertigo
viral infection
viral infection, CNS
viral isolation
visual evoked response
visual field defect
visual symptoms
walking, difficulty with
water channel antibodies
West Nile fever
wheelchair
Whipple's disease
white matter disease
white matter disease, periventricular
work loss
workup
Showing articles 500 to 550 of 4597 << Previous Next >>

Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage: The FUNC Score
Stroke 39:2304-2309, Rost,N.S.,et al., 2008

Multiple Sclerosis and Cannabis: A Cognitive and Psychiatric Study
Neurol 71:164-169, Ghaffar,O. &Feinstein,A., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Percutaneous Clot Removal Devices in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Arch Neurol 65:1024-1030, Stead,L.G.,et al., 2008

Hyperdense Internal Carotid Artery Sign: A CT Sign of Acute Ischemia
Stroke 39:2011-2016, Ozdemir,O.,et al, 2008

Effect of Laquinimod on MRI-Monitored Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIb Study
Lancet 371:2085-2092,2059, Comi,G.,etc., 2008

Diagnosis and Management of Motor Neurone Disease
BMJ 336:658-662, McDermott,C.J. &Shaw,P.J., 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Interferon �-Associated Retinopathy in Patients Treated for Multiple Sclerosis
Neurol 70:1153-1155, Folden,D.V.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

NMO-IgG Predicts the Outcome of Recurrent Optic Neuritis
Neurol 70:2197-2200, Matiello,M.,et al, 2008

Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis
NEJM 358:647-648, Mullen,J.T.,et al, 2008

Finding NMO: Neuromyelitis Optica in Chidlren
Neurol 70:334-335, Levy,M.,et al, 2008

Mitoxantrone as Induction Treatment in aggressive Relapsing Remitting Multiple Sclerosis: Treatment Response Factors in a 5 Year Follow-up Observational Study of 100 Consecutive Patients
JNNP 79:52-56, Le Page,E.,et al, 2008

Sporadic Adult-Onset Leukoencephalopathy with Neuroaxonal Spheroids Mimicking Cerebral MS
Neurol 70:1128-1133, Keegan,B.M.,et al, 2008

Picturing Multiple Sclerosis: Conventional and Diffusion Tensor Imaging
Semin Neurol 28:453-466, Fox,R.J., 2008

4-Aminopyridine Toxicity with Unintentional Overdose in Four Patients with Multiple Sclerosis
Neurol 71:1833-1834, Burton,J.M.,et al, 2008

Stroke and Multi-Infarct Dementia as Presenting Symptoms of Giant Cell Arteritis: Report of 7 Cases and Review of the Literature
Medicine 87:335-344, Solans-Laque,R.,et al, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Bal�s Disease Showing Benign Clinical Course and Co-Existence with Multiple Sclerosis-Like Lesions in Chinese
Multiple Sclerosis 14:418-424, Wang,C.,et al, 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

Non-Communicating Syringomyelia: A Feature of Spinal Cord Involvement in Multiple Sclerosis
Brain 131:1776-1782, Weier,K.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Course and Outcome of Acute Limbic Encephalitis With Negative Voltage-Gated Potassium Channel Antibodies
JNNP 78:391-394, Samarasekera,S.R., et al, 2007

Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging
AJNR 28:1639-1644, Ge,Y.,et al, 2007

Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol 64:1426-1432, de Seze,J.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 69:1552-1553, Sorenson,P.S. &Bertolotto,A., 2007

How Effective Are Disease-Modifying Drugs in Delaying Progression in Relapsing-Onset MS?
Neurol 69:1498-1507, Brown,M.G.,et al, 2007

What Do We Really See When We Look at Magnetic Resonance Images?
Ann Neurol 62:207-208, Filippi,M. &Hartung,H.-P., 2007

Rehabilitation for Spatial Neglect Improves Test Performance But Not Disability
Stroke 38:2869-2870, Bowen,A. &Lincoln,N.B., 2007

Treatment of Physicians With Epilepsy
Neurol 69:1374-1379, Allen,J.W. &Devinsky,O., 2007

Parental Transmission of MS in a Population-Based Canadian Cohort
Neurol 69:1208-1212,1202, Herrera,B.M.,et al, 2007

Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Predictors of Fitness to Drive in People With Parkinson Disease
Neurol 69:1434-1441, Devos,H.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Guidelines For Using Proton MR Spectroscopy in Multicenter Clinical MS Studies
Neurol 69:1942-1952, De Stefano,N.,et al, 2007

Long-Term Prognosis in Children With Neonatal Seizures: A Population-Based Study
Neurol 69:1816-1822, Ronen,G.M.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007



Showing articles 500 to 550 of 4597 << Previous Next >>